Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com
March 19, 2019DUBLIN–(BUSINESS WIRE)–The “Amblyopia
Global Clinical Trials Review, H2, 2018” clinical trials has
been added to ResearchAndMarkets.com’s offering.
Amblyopia Global Clinical Trials Review, H2, 2018″ provides an overview
of Amblyopia clinical trials scenario. This report provides top line
data relating to the clinical trials on Amblyopia. Report includes an
overview of trial numbers and their average enrollment in top countries
conducted across the globe.
The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database – Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.
Scope
- The report provides a snapshot of the global clinical trials landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
End point status -
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company -
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to Buy
-
Assists in formulating key business strategies with regards to
investment -
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost -
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities -
Supports understanding of trials count and enrollment trends by
country in global therapeutics market -
Aids in interpreting the success rates of clinical trials by providing
a comparative scenario of completed and uncompleted (terminated,
suspended or withdrawn) trials -
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Key Topics Covered:
- Report Guidance
- Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
-
Clinical Trials by G7 Countries: Proportion of Amblyopia to
Ophthalmology Clinical Trials - Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
-
Clinical Trials by E7 Countries: Proportion of Amblyopia to
Ophthalmology Clinical Trials - Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Amblyopia Therapeutics Clinical Trials
- Prominent Drugs
- Clinical Trial Profile Snapshots
- Appendix
Companies Mentioned
- Herantis Pharma Plc
- Santen Pharmaceutical Co Ltd
For more information about this clinical trials report visit https://www.researchandmarkets.com/research/2d325w/global_amblyopia?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Optical